Assuntos
Adulto , Eletrocardiografia , Evolução Fatal , Feminino , Humanos , Índia , Síndrome de Lutembacher/diagnóstico , Pessoa de Meia-Idade , Mães , Núcleo FamiliarAssuntos
Adolescente , Angiografia , Fístula Artério-Arterial/complicações , Angiografia Coronária , Anomalias dos Vasos Coronários/complicações , Vasos Coronários/patologia , Ecocardiografia Doppler , Eletrocardiografia , Cateterismo Cardíaco , Ventrículos do Coração , Humanos , Masculino , Tetralogia de Fallot/complicaçõesAssuntos
Angioplastia Coronária com Balão , Terapia Combinada , Seguimentos , Humanos , Infarto do Miocárdio/tratamento farmacológico , Ensaios Clínicos Controlados Aleatórios como Assunto , Estreptoquinase/uso terapêutico , Taxa de Sobrevida , Terapia Trombolítica , Fatores de Tempo , Ativador de Plasminogênio Tecidual/uso terapêutico , Grau de Desobstrução VascularRESUMO
The present report describes the clinical and angio-cardiographic features of 23 cases of tricuspid atresia. Nineteen patients had type I anatomy, 2 patients had type II anatomy and 2 patients had type III anatomy. In addition to the standard features, there were some uncommon associations observed. These included double outlet right ventricle, double outlet left ventricle, single coronary artery, complete heart block, right axis deviation, ostium primum atrial septal defect and coarctation of the aorta.
Assuntos
Adolescente , Angiocardiografia , Criança , Pré-Escolar , Feminino , Cardiopatias Congênitas/classificação , Doenças das Valvas Cardíacas/congênito , Ventrículos do Coração/diagnóstico por imagem , Humanos , Lactente , Masculino , Valva Tricúspide/anormalidadesRESUMO
Selective Beta Blocker Tenolol (IPCA) 50 mg. (A50) and 100 mg. (A100) single dose drug therapy was tried in 25 cases of angina pectoris. Hypertensives were excluded from trial. There were 4 diabetics. Drug trial over a period of 4 weeks revealed subjective and objective improvement with A50 and A100 assessed at the end of 2 and 4 weeks. The average angina attacks/2 wks. was 13.12 +/- 11.26 in basal state whereas the reduction in angina attacks was 6.285 +/- 8.80 with Tenolol 50 mg. and 3.72 +/- 2.86 with 100 mg which was statistically significant. Objective assessment of each patient done by Computerised Stress Test (CST) at the end of 2 and 4 weeks of Tenolol 50 mg and 100 mg revealed statistically significant improvement in their ST depression i.e. 3.645 +/- 1.463 mm basal ST depression, 1.692 +/- 1.680 after Tenolol 50 mg and 2.318 +/- 1.270 after Tenolol 100 mg. There was statistically significant fall in systolic BP (SBP) and double product (DP) both with A50 and 100 mg. Only one patient had slow ventricular tachycardia and mild hypotension during CST.